Differential effects of dihydropyridine calcium channel blockers in kainic acid-induced experimental seizures in rats

Epilepsy Research

Volumn 52, Issue 3, 2003, Pages 215-225

  Kriz, Jasna ^a,b   Župan, Gordana ^a   Simonić, Ante ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

EEG power spectra; Electroencephalograph; Nicardipine; Nifedipine; Nimodipine; Seizures

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CHLORAL HYDRATE; DIHYDROPYRIDINE DERIVATIVE; KAINIC ACID; NICARDIPINE; NIFEDIPINE; NIMODIPINE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTRODE; ELECTROENCEPHALOGRAPHY; FRONTAL CORTEX; HIPPOCAMPUS; INCISION; INJECTION; NONHUMAN; PARIETAL LOBE; POWER SPECTRUM; PRIORITY JOURNAL; RAT; SEIZURE; STEREOTAXIC SURGERY; SYRINGE;

ANIMALS; ANTICONVULSANTS; CALCIUM CHANNEL BLOCKERS; ELECTROENCEPHALOGRAPHY; EXCITATORY AMINO ACID AGONISTS; HIPPOCAMPUS; KAINIC ACID; RATS; RATS, WISTAR; SEIZURES;

EID: 0037234345     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(02)00213-9     Document Type: Article

References (38)

1. 3H]5-HT from CNS synaptosomes. Drugs Develop. 2:1993;437-445.
2. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 14:1985;375-403.
3. Ben-Ari Y., Cassart R. Kainate, a double agent that generates seizures: two decade of progress. Trends Neurosci. 23:2000;580-587.
4. Bingmann D., Speckmann E.J., Walden J., Straub H., Baker R.E., Ruijter J. Differential antiepileptic effects of organic calcium channel blockers in CA3 neurons of hippocampal slices and in neurons of organotypic neuronal explants. Klee M.R., Lux H.D., Speckmann E.J. Physiology, Pharmacology and Development of Epileptogenic Phenomena. 1991;233-236 Springer, Berlin.
5. Cano-Abad M.F., Villaroya M., Garcia A.G., Gabilau N.H., Lopez M.G. Calcium entry trough L-type calcium channels causes mitochondrial disruption and chromaffin cell death. J. Biol. Chem. 276:2001;39695-39704.
6. Charkrabarti A., Saini H.K., Garg S.K. Dose-finding study of nimodipine: a selective central nervous system calcium channel blocker on amynophylline induced seizures in rats. Brain Res. Bull. 45:1998;495-499.
7. Clemens B., Szigeti G., Barta Z. EEG frequency profiles of idiopathic generalized epilepsy syndromes. Epilepsy Res. 42:2000;105-115.
8. 3H] PY 108-068. J. Neural Transm. 60:1984;169-197.
9. Danks A.M., Hommond D.N., Wainer B.H., Van Buskirk R.G., Isaacson R.I. Cellular alterations produced by the experimental increase in intracellular calcium and the nature of protective effects of from pretreatment with nimodipine. Mol. Brain Res. 16:1992;168-172.
10. Dolin S.J., Hunter A.B., Halsey M.J., Little H.J. Anticonvulsant profile of the dihydropyridone calcium channel antagonists, nirendipine and nimodipine. Eur. J. Pharmacol. 152:1988;19-27.
11. Dolin S.J., Little H.J. The dihydropyridine nitrendipine prevents nitrous oxide withdrawal seizures in mice. Br. J. Addict. 81:1986;708.
12. Fischer R.S. Animal models of epilepsies. Brain Res. Rev. 16:1989;245-278.
13. Heinemann U., Lux H.D. Ionic changes during experimentally induced epilepsies. Rose F.C. Research Progress in Epilepsy. 1983;87-102 Pitman Books Limited, London.
14. Janis R.A., Triggle D.J. Drug acting on calcium channels. Hurwitz L.H., Partidge L.D., Leach J.K. Calcium Channels: their Properties, Functions, Regulation and Clinical Relevance. 1991;195-249 CRC Press, Boca Raton.
15. Kaminski R.M., Mazurek M., Turski W.A., Kleinrok Z., Czuczwar S.J. Amlodipine enhances the activity of antiepileptic drugs against pentylentetrazole-induced seizures. Pharmacol. Biochem. Behav. 68:2001;661-668.
16. Križ J., Župan G., Križ M., Simonić A. Effects of intrahippocamal injection of kainic acid on EEG and gross behavior in rats. Acta Fac. Med. Flum. 18:(Suppl. 1):1994;13-18.
17. Križ J., Župan G., Simonić A. Effects of nimodipine and nicardipine on EEG activity and power spectra in kainic-acid induced seizures in rats. Soc. Neurosci. Abste. 21:1995;202.
18. Little H.J., Dolin S.J., Halsey M.J. Calcium channel antagonists decrease the ethanol withdrawal syndrome. Life Sci. 39:1986;2059-2065.
19. Lothman E.W., Collins R.C., Ferrendelli J.A. Kainic acid-induced limbic seizures: electrophysiological studies. Neurology. 31:1981;806-812.
20. McNamara J.O. The neurobiological basis of epilepsy. Trends Neurosci. 15:1992;357-359.
21. Meyer F.B. Calcium, neuronal hyperexcitability and ischemic injury. Brain Res. Rev. 14:1989;227-243.
22. Meyer F.B., Anderson R.E., Sundt T.M. Jr., Yaksh T.L., Sharbrough F.W. Supression of pentilenetetrazole seizures by oral administration of a dihydropyridine calcium antagonist. Epilepsia. 28:1987;409-414.
23. Meyer F.B., Cascino G.D., Whisnant J.P., Sharbrough F.W., Ivnik R.J., Gorman D.A., Windschitl W.L., So E.L., O'Fallon W.M. Nimodipine as an add-on therapy for infractible epilepsy. Mayo Clin. Proc. 70:1995;623-627.
24. 2+ channel antagonist nimodipine on kainic acid-induced limbic seizures. Epilepsy Res. 6:1990;33-38.
25. Palmer G.C., Stagnitto M.L., Ray R.K., Knowels M.A., Harvey R., Garske G.E. Anticonvulsant properties of calcium channel blockers in mice: N-Methyl-D-,L-Aspartate-and Bay K 8644-induced convulsions are potently blocked by the dihydropyridines. Epilepsia. 34:1993;372-380.
26. Paxinos G., Watson C. The Rat Brain in the Stereotaxic Coordinates. 1982;Academic Press, Sydney, New York, London.
27. Pontecorvo M.J., Karbon E.W., Goode S., Clissold D.B., Borosky S.A., Patch R.J., Ferkony J.W. Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents. Brain Res. Bull. 25:1991;211-214.
28. Popoli P., Pezzola A., Scotti de Carolis A. Effects of calcium antagonist nimodipine on pentylenetetrazole-induced seizures in rats and rabbits. Arch. Int. Pharmacodyn. 292:1988;58-67.
29. Shelton R.C., Grebb J.A., Freed W.J. Induction of seizures in mice by intracerebroventricular administration of the calcium channel agonist BAY K 8644. Brain Res. 402:1987;399-402.
30. Speckmann E.J., Walden J. Supression of partial and generalized seizure activity by intracerebroventricular perfusion of the organic calcium channel antagonist verapamil in the rat. Klee M.R., Lux H.D., Speckmann E.J. Physiology, Pharmacology and Development of Epileptogenic Phenomena. 1991;229-232 Springer, Berlin.
31. Speckmann E.J., Walden J., Bingman D. Functional implications of calcium ions in epileptic seizures/antiepileptic effects of organic calcium antagonists. Arzmenim. Forsch/Drug. Res. 39:(Suppl. 1):1989;149-156.
32. Tanaka S., Sako K., Tanaka T., Yonemasu Y. Regional calcium accumulation and kainic acid (KA)-induced limbic seizures in rats. Brain Res. 478:1989;385-390.
33. Van Luijtelaar E.L.J.M., Ates N., Coenen A.M.L. Role of L-type calcium channel modulation in nonconvulsive epilepsy in rats. Epilepsia. 36:1995;86-92.
34. Van Luijtelaar E.L.J.M., Ates N., Van der Staay F.J. The effects of chronic treatment with a calcium channel antagonist on two types of generalized epilepsies in rats. Pharmacol. Biochem. Behav. 48:1994;575-579.
35. 2+ channel blockers in generalized epilepsy. Eur. J. Pharmacol. 406:2000;381-389.
36. Woodward J.J., Cook M.E., Leslie S.W. Characterization of DHP sensitive calcium channels in rat brain synaptosomes. Proc. Natl. Acad. Sci. 85:1988;7389-7393.
37. Zapatar P., Javaloy J., Roman J.F., Vidal M.T., Horga J.F. Anticonvulsant effects of nimodipine and two novel dihydropyridines (PCA 50922 and PCA 50941) against seizures elicited by pentilenetetrazole and electrocinvulsive shock in mice. Brain Res. 796:1998;311-314.
38. Župan G., Eraković V., Simonić A., Križ J., Varljen J. The influence of nimodipine, nicardipine and amlodipine on the brain free fatty acid level in rats with penicillin-induced seizures. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 23:1999;951-961.